Cell Machines

From edegan.com
Jump to navigation Jump to search


We have developed a scalable, multipurpose system for production of human therapeutic proteins that provides us with a tremendous cost advantage. Our first product is factor IX for the treatment of hemophilia B. This is currently an underserved $1.4 billion market. ...

Startup
Cell Machines
Project logo 02.png
Startup Information
Website cellmachines.net
Industry Therapeutics
Accelerator
Accelerator (Other)
Founder
Founding Date
Street Address
City
Zip Code
Copyright © 2016 McNair Center. All Rights Reserved.